Exhibit 99.2
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of Amendment No. 2 to the Schedule 13D originally filed on March 10, 2010 (including additional amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Orchid Cellmark Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
| Dated: September 7, 2010 | ACCIPITER LIFE SCIENCES FUND, LP |
| | |
| | By: | Candens Capital, LLC its general partner |
| | |
| | By: | /s/ Gabe Hoffman |
| | | Gabe Hoffman, Managing Member |
| | ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD. |
| | |
| | By: | Accipiter Capital Management, LLC its investment manager |
| | |
| | By: | /s/ Gabe Hoffman |
| | | Gabe Hoffman, Managing Member |
| | ACCIPITER CAPITAL MANAGEMENT, LLC |
| | |
| | By: | /s/ Gabe Hoffman |
| | | Gabe Hoffman, Managing Member |
| | CANDENS CAPITAL, LLC |
| | |
| | By: | /s/ Gabe Hoffman |
| | | Gabe Hoffman, Managing Member |
| | /s/ Gabe Hoffman |
| | GABE HOFFMAN |
